Related Experiment Video
Updated: Jun 28, 2026
08:56
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Hepatic fibrosis: can we treat it clinically?
1Division of Hepatology, School of Digestive and Liver Diseases, Institute of Post Graduate Medical Education & Research, Kolkata.
Tropical Gastroenterology : Official Journal of the Digestive Diseases Foundation
|November 1, 2008
Summary
Liver fibrosis, once irreversible, can now regress with targeted therapies. New anti-fibrotic drugs and precise endpoints offer hope for treating chronic liver disease and cirrhosis.
Area of Science:
- Hepatology and Regenerative Medicine
- Fibrosis Research and Therapeutics
Background:
- Hepatic fibrosis is a critical factor in chronic liver disease progression and cirrhosis outcomes.
- Historically viewed as irreversible, emerging data suggests liver fibrosis regression is achievable.
Purpose of the Study:
- To discuss the evolving landscape of hepatic fibrosis treatment, emphasizing regression and improved outcomes.
- To highlight the need for precise endpoints to evaluate anti-fibrotic therapies.
- To propose a proactive, dual approach combining etiological treatment with anti-fibrotics for chronic liver disease.
Main Methods:
- Review of current clinical and laboratory data on liver fibrosis regression.
- Discussion of existing and emerging anti-fibrotic therapeutic strategies.
- Exploration of the 'hit the enemy and repair the hut' treatment paradigm.
Main Results:
- Successful treatment of underlying liver inflammation and injury can lead to fibrosis reversal and cirrhosis improvement.
- Novel anti-fibrotic agents targeting collagen dynamics are under evaluation.
- The development of clear endpoints is crucial for assessing anti-fibrotic therapy efficacy.
Conclusions:
- A shift from pessimism to optimism in chronic liver disease management is warranted.
- Aggressive, combined therapeutic strategies ('hit the enemy and repair the hut') represent a new era in treating liver fibrosis and cirrhosis.
- Future management will likely involve addressing the cause of liver injury alongside targeted anti-fibrotic interventions.
Related Concept Videos
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:24Liver Regeneration
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...